Market Place
Sourcing Support
All News #Library
Sciences
OpenFold AI Consortium Welcomes Six New Members
13 Aug 2024 //
BUSINESSWIRE
Siemens Healthineers nets CE Mark for MS relapse risk blood test
17 Jun 2024 //
FIERCE BIOTECH
Data manipulation scientist Elisabeth Bik on Cassava, Athira
23 Nov 2021 //
FIERCEBIOTECH
Pfizer, Novartis, & other biotechs sign onto NIH/FDA program for rare diseases
27 Oct 2021 //
ENDPTS
Biogen-Eisai, Samsung-Roche, Sunovion-Otsuka—Fierce Pharma Asia
01 Oct 2021 //
FIERCEPHARMA
Alzheimer`s drug prospect may be safer than Biogen`s aducanumab
18 Feb 2021 //
FIERCEBIOTECH
Buzzy anti-aging biotech Unity drops leading program
17 Aug 2020 //
FIERCEBIOTECH
Coronavirus delays Biogen`s Spinraza for some patients
20 Mar 2020 //
REUTERS
Canadian star researcher brandishes Deep Genomics` first AI-discovered drug
25 Sep 2019 //
ENDPTS
Developing a Ketone Body-Based Drug to Combat Alzheimer’s Disease
11 Jul 2019 //
BIOSPACE
Improving memory by changing brain waves
13 Jun 2019 //
FIERCE BIOTECH
Pharmacquired: Biogen could use a big deal
22 Mar 2019 //
BIOPHARMA DIVE
Partnering talks led to Biogen’s $800M Nightstar buyout
18 Mar 2019 //
ENDPTS
Is Biogen’s Aducanumab for Alzheimer’s the Holy Grail or Cold Fusion?
03 Feb 2019 //
BIOSPACE
Biogen leaves analysts guessing on aducanumab
29 Jan 2019 //
BIOPHARMA DIVE
C4 Therapeutics, Biogen buys more shots on goal on SMA, Alzheimer’s
04 Jan 2019 //
ENDPTS
Banner Receives FDA Tentative Approval for BAFIERTAM for Multiple Sclerosis
03 Jan 2019 //
BUSINESSWIRE
A new analysis spotlights the top 20 drugs in the late-stage pipeline
14 Dec 2018 //
ENDPTS
HitGen & Biogen enter a Drug Discovery Research Collaboration
21 Nov 2018 //
BUSINESSWIRE
Biogen’s ‘positive’ Alzheimer’s trial has a problem with small numbers
25 Oct 2018 //
STAT NEWS
Newly discovered ALS mechanism could point the way to novel drugs
06 Sep 2018 //
FIERCE BIOTECH
Positive Ph III Results for Genentech’s HEMLIBRA published in NEJM
30 Aug 2018 //
BUSINESSWIRE
Preparing for the big biologic switch
17 Aug 2018 //
PHARMACEUTICAL JOURNAL
Mallinckrodt doses first patient in muscular dystrophy trial
03 Aug 2018 //
PM LIVE
Why the Latest Alzheimer’s Drug Study Has So Many People Confused
30 Jul 2018 //
FORTUNE
Advancing Complex Trial Designs: FDA Discusses Upcoming Pilot Program
20 Mar 2018 //
RAPS
5 Top Biotech Stocks That Look Vulnerable in 2018
09 Jan 2018 //
BIOSACE
Will These Cutting-Edge Cancer Killers Reignite The Biotech Rally?
15 Jun 2017 //
NASDAQ
Global Neurodegenerative Drugs Market to Hit $45B by 2022
09 Dec 2016 //
DDDMAG
What Are Analysts Saying About Q2 at Biotech`s Big 4? Amgen, Biogen, Celgen
28 Jul 2016 //
FORBES
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.